Zentiva’s $36 Million Acquisition of Ankleshwar

Khaitan & Co advised Zentiva Group in relation to purchase of the API manufacturing facility of Sanofi India Limited situated at Ankleshwar, Gujarat.

Zentiva Group, a.s. signed a Business Transfer Agreement with Sanofi to acquire their manufacturing site in Ankleshwar, India. This acquisition will help ensure the continued supply of high-quality medicines to more patients by expanding the footprint and agility of Zentiva’s manufacturing network.

With demand for high quality and affordable medicines increasing, the acquisition reaffirms Zentiva’s commitment to stand side-by-side with pharmacists, healthcare professionals and decision makers in improving access for patients.

Earlier in 2019, Zentiva enhanced its network with the acquisition of Solacium in Romania and Creo in the United Kingdom, as well as making multi-million Euro investments in Prague and Bucharest to maximize manufacturing capabilities.

Khaitan & Co advised Zentiva Group on the deal with a team including Surbhi Kejriwal (Picture), Varun Narayan, Kanika Mathew (corporate), Shantanu Gupta, Sneha Oak Joshi, Srijanee Bhattacherjee (Due Diligence), Anshul Prakash, Abhimanyu Pal (Employment), Atul Pandey and Hirak Mukhopadhyay (Regulatory).

Involved fees earner: Shantanu Gupta – Khaitan & Co.; Surbhi Kejriwal – Khaitan & Co.; Atul Pandey – Khaitan & Co.; Anshul Prakash – Khaitan & Co.;

Law Firms: Khaitan & Co.;

Clients: Zentiva Pharma GmbH;

Print Friendly, PDF & Email

Author: Michael Patrini